AL
ITCI icon

Airain Ltd’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Airain Ltd’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-4,604
Closed -$248K – 1111
2015
Q4 		$248K Sell
4,604
-1,804
-28% -$91K 0.02% 666
2015
Q3 		$257K Buy
+6,408
New +$209K 0.02% 633

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TimesSquare Capital Management
TimesSquare Capital Management New York $6.8B AUM 45.85% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BlackRock Advisors
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return

Airain Ltd's ITCI Position: Q1 2016 in Review

Airain Ltd sold out of Intra-Cellular Therapies Inc. (ITCI) in Q1 2016, closing a stake of 4,604 shares — an estimated $248K sold.

Airain Ltd first reported a position in ITCI in Q3 2015 and held it in 2 quarters. The position peaked at $257K in Q3 2015. 127 funds tracked by Wall St. Rank hold ITCI as of Q1 2016.

  • Airain Ltd reported no remaining Intra-Cellular Therapies Inc. position as of Q1 2016 after selling out during the quarter.
  • Airain Ltd sold 4,604 Intra-Cellular Therapies Inc. shares in Q1 2016, an estimated $248K.
  • Airain Ltd first reported a position in Intra-Cellular Therapies Inc. in Q3 2015 and held it in 2 quarters.
  • Airain Ltd's Intra-Cellular Therapies Inc. position peaked at $257K in Q3 2015.
  • 127 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q1 2016.

Based on Airain Ltd's 13F filing for Q1 2016, filed 9 May 2016.